Verification evidence is still being completed.
Asper Biogene
Tartu, Estonia
- Verified lead
- Hardi Tamm
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Genetic Testing, NGS Services, and Clinical Diagnostic Panels
- Review cycle
- May 2026
- Full address
- Vaksali 17a, 50410 Tartu, Estonia
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Asper Biogene management-team page confirming the current executive lead in Tartu.
- Editorial note
- Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Genetic Testing, NGS Services, and Clinical Diagnostic Panels
ISO 15189:2012 #M014, ISO 9001:2015 #EST04518A, Health Board licence #L01469
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
- Website
- asperbio.com
- Company page
- Lead
- Hardi Tamm (verified ↗)
- Compliance
- ISO 15189:2012 #M014 · ISO 9001:2015 #EST04518A
- Last reviewed
- 21 Mar 2026 (4mo ago)
- Scale
- Clinical genetic testing and sequencing services
- Capabilities
- Disease-Specific DNA Panels · Whole Exome and Genome Testing · Clinical Genetic Diagnostics
- Founded
- 1999
- Headcount
- 11-50
Genetic Testing, NGS Services, and Clinical Diagnostic Panels
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation.
Verification details
Hardi Tamm
Chief Executive Officer
Official Asper Biogene contacts page listing the Vaksali 17a Tartu diagnostic site.
Open sourceClinical genetic testing and sequencing services
Tartu, Estonia. Genetic Testing, NGS Services, and Clinical Diagnostic Panels. Review completed on 21 Mar 2026.
Estonian Health Board and ISO-accredited laboratory oversight
ISO 15189:2012 #M014, ISO 9001:2015 #EST04518A, Health Board licence #L01469
Capabilities
Sources
The official sources used to verify this profile.
Infrastructure
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
Frequently asked questions
- Where is Asper Biogene located?
- Asper Biogene operates from Vaksali 17a, 50410 Tartu, Estonia, Tartu, Estonia.
- Who runs Asper Biogene?
- Asper Biogene is led by Hardi Tamm, Chief Executive Officer. Verified 21 Mar 2026.
- What certifications does Asper Biogene hold?
- Asper Biogene is documented under ISO 15189:2012 #M014, ISO 9001:2015 #EST04518A.
- What does Asper Biogene do?
- Asper Biogene adds an Estonia genomics node with a source-backed CEO, a fixed Tartu diagnostic site, and official ISO 15189 / Health Board disclosures tied to the laboratory operation. Core capabilities: Disease-Specific DNA Panels, Whole Exome and Genome Testing, Clinical Genetic Diagnostics.
Related technical briefs
Briefs that name Tartu as a covered market or city.
